Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xuhan Zhang

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Experimental Hematology & Oncology|June 21, 2023
A new dosing regimen of ropeginterferon alfa-2b is highly effective and tolerable: findings from a phase 2 study in Chinese patients with polycythemia veraJie Jin, Lei Zhang, Albert Qin, et al.
Bone Marrow Transplantation|February 27, 2019
Retrospective cohort study comparing the outcomes of intravenous busulfan vs. total-body irradiation after single cord blood transplantationBaolin Tang, Xiaoyu Zhu, Changcheng Zheng, et al.
Med (New York, N.Y.)|February 1, 2025
HMPL-306 in relapsed or refractory IDH1- and/or IDH2-mutated acute myeloid leukemia: A phase 1 studyLijuan Hu, Xudong Wei, Weili Zhao, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 26, 2026
A Non-Canonical Role of SMAD4 in Regulating 3D Genome Architecture to Inhibit Lung Squamous Cell Carcinoma DevelopmentQian Tang, Chen Lian, Xinyan Han, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Experimental Hematology & Oncology|June 21, 2023
A new dosing regimen of ropeginterferon alfa-2b is highly effective and tolerable: findings from a phase 2 study in Chinese patients with polycythemia veraJie Jin, Lei Zhang, Albert Qin, et al.
Bone Marrow Transplantation|February 27, 2019
Retrospective cohort study comparing the outcomes of intravenous busulfan vs. total-body irradiation after single cord blood transplantationBaolin Tang, Xiaoyu Zhu, Changcheng Zheng, et al.
Med (New York, N.Y.)|February 1, 2025
HMPL-306 in relapsed or refractory IDH1- and/or IDH2-mutated acute myeloid leukemia: A phase 1 studyLijuan Hu, Xudong Wei, Weili Zhao, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 26, 2026
A Non-Canonical Role of SMAD4 in Regulating 3D Genome Architecture to Inhibit Lung Squamous Cell Carcinoma DevelopmentQian Tang, Chen Lian, Xinyan Han, et al.
Pageof 5